OncoMASTER and NOVO Genomics Sign MOU for Groundbreaking Precision Oncology Feasibility Studies in Saudi Arabia
Seoul, South Korea & Riyadh, Saudi Arabia; 19 November2024: OncoMASTER, a Korea-based leader in precision oncology, and NOVO Genomics, a pioneering Saudi biotech company, have signed a Memorandum of Understanding…
